Pfizer's case for boosters — China's surging biotech scene — Israel's crucial study

Your daily healthcare analysis.

Subscribe to Insider View in browser       Hello, Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news: We dug into Pfizer's case for COVID-19 booster shots; Inside China's quiet growth into a biotech powerhouse; What a massive study from Israel can tell us about about the risk of severe COVID-19 in older adults after a third shot. If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it... FDA releases documents outlining Pfizer's case for COVID-19 booster shots The FDA released documents Wednesday giving a look at Pfizer's case for COVID-19 booster shots. The data shows a third dose of Pfizer's shot raised antibody levels with no major safety concerns. An expert panel will make recommendations to the FDA on booster shots on Friday. Here's what you need to know>> How China quietly grew into a biotech powerhouse that will shape the future of the drug industry China's biotech industry has surged in recent years following regulatory and stock-market changes. These biotechs have opened US headquarters and received FDA approval for new cancer treatments. They will "be global competitors, and there may be global implications," a noted investor said. Get the full story>> A massive study from Israel suggests older adults were far less likely to develop severe COVID-19 after a booster shot, but the finding carries major limitations A third dose of Pfizer's coronavirus vaccine dramatically reduces the risk of infection and severe illness for older adults, a new study found. A team of researchers in Israel published the findings Wednesday in The New England Journal of Medicine. Still, an expert urged caution on interpreting the findings, saying the study has major limitations. Find out more>> More stories we're reading:  The most common side effects to expect after your Pfizer booster: headache, fatigue, and pain at the injection site (Insider) A boy's appendix burst while waiting hours at a COVID-19-swamped ER (ProPublica) Beyond COVID-19 vaccines, mRNA's pioneers have big plans for using the technology against a range of diseases (Insider) 1 in 500 people in the US have died from COVID-19 (CNN) - Lydia           Was this email forwarded to you? SUBSCRIBE NOW     You received this email because you signed up to this Insider newsletter using the email: aymentanaze.news@blogger.com   Email preferences Unsubscribe TERMS OF SERVICE PRIVACY POLICY 1 Liberty Plaza, 8th Floor. New York, NY 10006